login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
VERTEX PHARMACEUTICALS INC (VRTX) Stock News
USA
- NASDAQ:VRTX -
US92532F1003
-
Common Stock
386.95
USD
-0.2 (-0.05%)
Last: 9/18/2025, 10:46:09 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VRTX Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Screens as a Top Undervalued Stock with Strong Fundamentals
7 days ago - By: Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Technical Breakout Potential
3 hours ago - By: Vertex Pharmaceuticals
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
17 hours ago - By: Zacks Investment Research
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
a day ago - By: The Motley Fool
- Mentions:
ISRG
2 Growth Stocks to Buy and Hold Forever
a day ago - By: The Motley Fool
- Mentions:
META
NVDA
Why This Biotech Company Could Be a Growth Stock Powerhouse
7 days ago - By: Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
7 days ago - By: Vertex Pharmaceuticals Incorporated
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis
8 days ago - By: Zacks Investment Research
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade
15 days ago - By: Benzinga
Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews
15 days ago - By: Zacks Investment Research
- Mentions:
AGIO
Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?
15 days ago - By: Yahoo Finance
Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List
15 days ago - By: Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Top GARP Stock with Strong Growth and Reasonable Valuation
16 days ago - By: Chartmill
- Mentions:
APA
ALB
STZ
BG
...
Tuesday's session: top gainers and losers in the S&P500 index
16 days ago - By: Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings
20 days ago - By: Zacks Investment Research
- Mentions:
BEAM
NTLA
CRSP
Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?
21 days ago - By: Zacks Investment Research
- Mentions:
BEAM
CRSP
CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?
22 days ago - By: Zacks Investment Research
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
25 days ago - By: Yahoo Finance
This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?
a month ago - By: Zacks Investment Research
- Mentions:
BEAM
NTLA
CRSP
CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock
a month ago - By: Vertex Pharmaceuticals Incorporated
Vertex to Participate in Upcoming September Investor Conferences
a month ago - By: Yahoo Finance
What's Wrong With Vertex Pharmaceuticals Stock?
Please enable JavaScript to continue using this application.